Brainsway (BWAY) Revenue Growth (1y) (2019 - 2026)
Brainsway (BWAY) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | 6.08% |
| 10 | Brainsway | 588.32 Mn | 528.55 Mn | 11.68 Mn | 34.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.63% |
| Dec 31, 2025 | 27.43% |
| Sep 30, 2025 | 28.66% |
| Jun 30, 2025 | 26.26% |
| Mar 31, 2025 | 26.84% |
| Dec 31, 2024 | 26.41% |
| Sep 30, 2024 | 26.50% |
| Jun 30, 2024 | 27.79% |
| Mar 31, 2024 | 37.28% |
| Dec 31, 2023 | 49.66% |
| Sep 30, 2023 | 60.64% |
| Jun 30, 2023 | -2.21% |
| Mar 31, 2023 | -16.88% |
| Dec 31, 2022 | -28.77% |
| Sep 30, 2022 | -35.89% |
| Jun 30, 2022 | 14.29% |
| Mar 31, 2022 | 30.21% |
| Dec 31, 2021 | 19.87% |
| Sep 30, 2021 | 34.04% |
| Jun 30, 2021 | 45.33% |